Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) on Ophthalmologic Assessments in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) Patients: Results From a 1-Year, Randomized, Controlled Clinical Trial